Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
Article in Breast Cancer Targets and Therapy (November 2021)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review
Article in The Oncologist (June 2021)
Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review
Article in PharmacoEconomics (March 2021)